DePuy Synthes, Inc., Zimmer Holding, and Stryker Corporation had made a name for themselves in global regenerative medicine market for bone and joint applications in 2012, when they had collectively taken up a value-based share of 59%. The three leaders are still expanding their scope of development as well as regional reach within this market.
According to a research report released by Transparency Market Research, the competitive edge in the global regenerative medicine market for bone and joint applications is expected to stay sharp over the coming years. The scope of advancements in technology within this market are extremely high and the prominent players are investing heavily in research and development efforts. Additionally, mergers and acquisitions are likely to remain consistently high over the coming years.
The global market for regenerative medicine for bone and joint applications is expected to reach US$6.47 bn by the end of 2019. This revenue is slated to expand at a CAGR of 12.8% within a forecast period from 2013 to 2019. By the end of 2016, the market is expected to reach US$4.80 bn. Biomaterials are expected to retain their lead in the global regenerative medicine market for bone and joint applications till 2019, when this technology segment is expected to reach US$4.05 bn.
Tissue Engineering Shows Great Promise in Key Applications
In terms of technology types, the global regenerative medicine market for bone and joint applications is currently dominated by biomaterials. They are used extensively for bone grafts as a form of substitute. At the same time, the market is witnessing a surge in demand for tissue engineering. This technology segment is expected to expand at a whopping CAGR of 19.8% from 2013 to 2019. Tissue engineering is finding a massive scope of use in the treatment of nerve tissue, skeletal tissue, skin, blood vessels, cartilage, bones, and even complete organs. The opportunities provided by developments in tissue engineering are being considered heavily by several key players at the moment, including Arthrex, Inc. and DePuy Synthes, Inc.
Orthopedic Surgeries on the Rise as Healthcare Focuses on Regenerative Medicine
“The prevalence of bone and joint disorders in the world today is quite alarming. The CDC predicted that the count of U.S. citizens over 18 by the end of 2030 suffering from arthritis would reach 67 mn. Healthcare research organizations the world over are agreeing on the fact that arthritis is a leading cause of severe discomfort and disability among the geriatric. It therefore takes a core role in driving the demand for developments in bone and joint treatments, and at the top of this chain lie the latest innovations in regenerative medicine,” states a TMR analyst.
The overall count of orthopedic surgeries is increasing globally, with more and more people in need of spinal fusions, partial or full hip replacements, and knee reconstruction. The AAOS had stated that more than 3 mn complete knee anthroplasties will be performed in the U.S. by 2030. A similar trend of growing number of surgeries is expected to be followed for all common bone and joint disorders.
Post-implant Infection Rates Still High Enough to Hinder Growth of Regenerative Medicine Demand
The global regenerative medicine market for bone and joint applications holds two inherent restraints at the moment. One of them is the highly concerning fact of post-implant infections. Both implant-based infections and implant failures are still problems that need to be resolved by researchers for regenerative medicine. The second core restraint on the global regenerative medicine market for bone and joint applications is the ethical issue of using stem cells through the artificial creation of an embryo in research facilities. This is a key ethical dilemma, especially when bundled with the problem that arises through the commercial usage of adult stem cells.
“The emerging economies from Asia Pacific and Latin America stand to provide great revenue streams to players in the global regenerative medicine market for bone and joint applications. The proliferation of regenerative medicine in these regions is a key opportunity for players in this market to make the most of their available technologies, while proceeding with innovative efforts for new ones,” adds the analyst.
The information presented in this review is based on a Transparency Market Research report, titled, “Regenerative Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019.”
Key Segments of the Global Regenerative Medicine Market for Bone and Joint Applications
Global Regenerative Medicine (Bone and Joint) Market by Technology
- Stem Cells
- Tissue Engineering
Global Regenerative Medicine (Bone and Joint) Market by Application
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
Global Regenerative Medicine (Bone and Joint) Market by Geography
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
7 of 10 large enterprizes view our ToC to take the right decision.View Report ToC